Silverarc Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-124,388	Closed	-$5.23M	–	77
2024 Q4	$5.23M	Buy	+124,388	New	+$5.23M	1.14%	30